Newsletter Year 3Read more
Coordinated by Duncan Sutherland (partner 2) in collaboration with partners 1a, 2 and 11
Nanostructured materials obtained in WP2 will be prepared on catheters and used to study complement and contact system activation. The most promising nanostructured or combined nanostructure with conjugated materials selected from WP2 and WP4 will be assessed for use on catheters from partner 11. The nanostructured catheters will be evaluated with respect to blood compatibility and inflammatory biomaterial response as well as bacterial adhesion, where the objective is to demonstrate a catheter with low activation compared to conventionally produced catheters.